334 related articles for article (PubMed ID: 12084445)
1. Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration.
Hosaka K; Ishii K; Sakamoto S; Mori T; Sasaki M; Hirono N; Mori E
J Neurol Sci; 2002 Jul; 199(1-2):67-71. PubMed ID: 12084445
[TBL] [Abstract][Full Text] [Related]
2. Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysis.
Juh R; Pae CU; Kim TS; Lee CU; Choe B; Suh T
Neurosci Lett; 2005 Jul 22-29; 383(1-2):22-7. PubMed ID: 15936506
[TBL] [Abstract][Full Text] [Related]
3. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
Juh R; Kim J; Moon D; Choe B; Suh T
Eur J Radiol; 2004 Sep; 51(3):223-33. PubMed ID: 15294329
[TBL] [Abstract][Full Text] [Related]
4. Voxel-based distribution of metabolic impairment in corticobasal degeneration.
Garraux G; Salmon E; Peigneux P; Kreisler A; Degueldre C; Lemaire C; Destée A; Franck G
Mov Disord; 2000 Sep; 15(5):894-904. PubMed ID: 11009197
[TBL] [Abstract][Full Text] [Related]
5. Cerebral glucose metabolism in corticobasal degeneration: comparison with progressive supranuclear palsy and normal controls.
Nagahama Y; Fukuyama H; Turjanski N; Kennedy A; Yamauchi H; Ouchi Y; Kimura J; Brooks DJ; Shibasaki H
Mov Disord; 1997 Sep; 12(5):691-6. PubMed ID: 9380049
[TBL] [Abstract][Full Text] [Related]
6. [A study on the cerebral glucose metabolism in progressive supranuclear palsy].
Ma AJ; Guo XJ; Li DC; Zhang BS; Pan XD
Zhonghua Nei Ke Za Zhi; 2012 Nov; 51(11):885-8. PubMed ID: 23291028
[TBL] [Abstract][Full Text] [Related]
7. A disease-specific metabolic brain network associated with corticobasal degeneration.
Niethammer M; Tang CC; Feigin A; Allen PJ; Heinen L; Hellwig S; Amtage F; Hanspal E; Vonsattel JP; Poston KL; Meyer PT; Leenders KL; Eidelberg D
Brain; 2014 Nov; 137(Pt 11):3036-46. PubMed ID: 25208922
[TBL] [Abstract][Full Text] [Related]
8. Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia.
Garraux G; Salmon E; Degueldre C; Lemaire C; Laureys S; Franck G
Neuroimage; 1999 Aug; 10(2):149-62. PubMed ID: 10417247
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography in degenerative disorders of the dopaminergic system.
Karbe H; Holthoff V; Huber M; Herholz K; Wienhard K; Wagner R; Heiss WD
J Neural Transm Park Dis Dement Sect; 1992; 4(2):121-30. PubMed ID: 1571076
[TBL] [Abstract][Full Text] [Related]
10. Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD.
Beretta L; Caminiti SP; Santangelo R; Magnani G; Ferrari-Pellegrini F; Caffarra P; Perani D
Neuropsychologia; 2019 Oct; 133():107174. PubMed ID: 31446008
[TBL] [Abstract][Full Text] [Related]
11. Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease.
Garcia-Garcia D; Clavero P; Gasca Salas C; Lamet I; Arbizu J; Gonzalez-Redondo R; Obeso JA; Rodriguez-Oroz MC
Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1767-77. PubMed ID: 22872307
[TBL] [Abstract][Full Text] [Related]
12. Familial progressive supranuclear palsy: detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography.
Piccini P; de Yebenez J; Lees AJ; Ceravolo R; Turjanski N; Pramstaller P; Brooks DJ
Arch Neurol; 2001 Nov; 58(11):1846-51. PubMed ID: 11708994
[TBL] [Abstract][Full Text] [Related]
13. Midbrain hypometabolism as early diagnostic sign for progressive supranuclear palsy.
Mishina M; Ishii K; Mitani K; Ohyama M; Yamazaki M; Ishiwata K; Senda M; Kobayashi S; Kitamura S; Katayama Y
Acta Neurol Scand; 2004 Aug; 110(2):128-35. PubMed ID: 15242422
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET study on the idiopathic Parkinson's disease from several parkinsonian-plus syndromes.
Zhao P; Zhang B; Gao S
Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S60-2. PubMed ID: 22166456
[TBL] [Abstract][Full Text] [Related]
15. Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: a head-to-head comparison.
Hellwig S; Reinhard M; Amtage F; Guschlbauer B; Buchert R; Tüscher O; Weiller C; Niesen WD; Meyer PT
Eur J Neurol; 2014 Jun; 21(6):860-6. PubMed ID: 24602186
[TBL] [Abstract][Full Text] [Related]
16. FDG-PET patterns associated with underlying pathology in corticobasal syndrome.
Pardini M; Huey ED; Spina S; Kreisl WC; Morbelli S; Wassermann EM; Nobili F; Ghetti B; Grafman J
Neurology; 2019 Mar; 92(10):e1121-e1135. PubMed ID: 30700592
[TBL] [Abstract][Full Text] [Related]
17. PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
Kurata T; Kametaka S; Ohta Y; Morimoto N; Deguchi S; Deguchi K; Ikeda Y; Takao Y; Ohta T; Manabe Y; Sato S; Abe K
Intern Med; 2011; 50(22):2775-81. PubMed ID: 22082889
[TBL] [Abstract][Full Text] [Related]
18. [¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
Hellwig S; Amtage F; Kreft A; Buchert R; Winz OH; Vach W; Spehl TS; Rijntjes M; Hellwig B; Weiller C; Winkler C; Weber WA; Tüscher O; Meyer PT
Neurology; 2012 Sep; 79(13):1314-22. PubMed ID: 22914831
[TBL] [Abstract][Full Text] [Related]
19. Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts.
Ge J; Wu J; Peng S; Wu P; Wang J; Zhang H; Guan Y; Eidelberg D; Zuo C; Ma Y
Hum Brain Mapp; 2018 Jul; 39(7):2842-2858. PubMed ID: 29536636
[TBL] [Abstract][Full Text] [Related]
20. Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography.
Foster NL; Gilman S; Berent S; Morin EM; Brown MB; Koeppe RA
Ann Neurol; 1988 Sep; 24(3):399-406. PubMed ID: 3265862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
